Mis à jour le 16/05/2021

Publications

Publications PubMed.gov

Publications sur PubMed (à partir de 2016) et ScienceDirect (à partir de 2020)

Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns

Lalevée S, Audureau E, Riou A, Colin A, Anquetin M, Barau C, Valeyrie-Allanore L, Delfau-Larue MH, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Hüe S. Clin Exp Allergy. 2019 Sep;49(9):1258-1261. doi: 10.1111/cea.13449. Epub 2019 Jul 7. PMID: 31206897. No abstract available.
Acute generalized exanthematous pustulosis induced by enoxaparin: 2 cases. Contact Dermatitis
Assier H, Gener G, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S. 2020 Nov 1. doi: 10.1111/cod.13734. Epub ahead of print. PMID: 33131094.
Adenovirus-induced Erythema Multiforme: Eye and Genital Mucosal Involvement is Specific, Whereas Oral and Cutaneous Involvement is Not
Calas A, Lheure C, Bernigaud C, Meritet JF, Sohier P, Augustin J, Isnard C, Franck N, Royer G, Ingen-Housz-Oro S, Dupin N. Acta Derm Venereol. 2020 Jun 11;100(13):adv00181. doi: 10.2340/00015555-3547. PMID: 32511743
Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis)
Lalevée S, Contassot E, Ortonne N, Gaudin O, Ben Said B, Vocanson M, De Prost N, Wolkenstein P, Hue S, Ingen-Housz-Oro S. Ann Dermatol Venereol. 2020 Jun-Jul;147(6-7):475-481. doi: 10.1016/j.annder.2020.02.010. Epub 2020 Apr 3. PMID: 32253008 French. No abstract available.
A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices
Kechichian E, Ingen-Housz-Oro S, Sbidian E, Hemery F, Bernier C, Fite C, Delaunay J, Staumont-Sallé D, Toukal F, Dupin N, Abasq C, Samimi M, Picard C, Hebert V, Prost C, Monfort JB, Milpied B, Wolkenstein P, Chosidow O. Br J Dermatol. 2018. PMID: 29957881 Clinical Trial. No abstract available.
Association Between Severe Acute Contact Dermatitis Due to Nigella sativa Oil and Epidermal Apoptosis
Gaudin O, Toukal F, Hua C, Ortonne N, Assier H, Jannic A, Giménez-Arnau E, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S. JAMA Dermatol. 2018 Sep 1;154(9):1062-1065. doi: 10.1001/jamadermatol.2018.2120. PMID: 30073256 Free PMC article.
Atypical bullous dermatosis: from suspected drug reaction to misdiagnosed occult epilepsy. Two challenging cases
Giraud-Kerleroux L, Charpentier C, Bernigaud C, Ortonne N, Hua C, Gaudron S, Nguyen QTR, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S. J Burn Care Res. 2020 Oct 22:iraa184. doi:10.1093/jbcr/iraa184. Epub ahead of print. PMID: 33091119.

Carrying out local care for epidermal necrolysis: survey of practices
Ingen-Housz-Oro S, Le Floch R, Alves A, Colin A, Ouedraogo R, Welfringer A, Dereure O, Besnard N, Bodemer C, Bernier C, Hoffmann C, Tétart F, Carpentier D, Cordel N, Elie E, Tauber M, Soubiron L, Milpied B, de Prost N. J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16884. Epub ahead of print. PMID: 32810302.
Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causes
Amode R, Ingen-Housz-Oro S, Ortonne N, Bounfour T, Pereyre S, Schlemmer F, Bequignon E, Royer G, Wolkenstein P, Chosidow O. J Am Acad Dermatol. 2018 Jul;79(1):110-117.doi: 10.1016/j.jaad.2018.03.013. Epub 2018 Mar 17. PMID: 29559400.
Chronic pain: a long-term sequela of epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) - prevalence, clinical characteristics and risk factors
Lefaucheur JP, Valeyrie-Allanore L, Ng Wing Tin S, Abgrall G, Colin A, Hajj C, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O. J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16891. Epub ahead of print. PMID: 32810314.
Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions
Bérot V, Gener G, Ingen-Housz-Oro S, Gaudin O, Paul M, Chosidow O, Wolkenstein P, Assier H. . J Eur Acad Dermatol Venereol. 2020 Apr;34(4):787-794. doi: 10.1111/jdv.15986. Epub 2019 Oct 28. PMID:31571276.
Crystal-clear blister fluid with low albumin concentration during toxic epidermal necrolysis
Contou D, Flores-Paraire L, Ortonne N, Chosidow O, de Prost N. Burns. 2016 Sep;42(6):1360-1. doi: 10.1016/j.burns.2016.03.031. Epub 2016 Jun 20. PMID: 27338179. No abstract available.
Cutaneous tests and interest of iobitridol in non-immediate hypersensitivity to contrast media: a case series of 43 patients
Gaudin O, Deschamps O, Duong TA, Gener G, Paul M, Luciani A, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Assier H. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):e178-e180. doi: 10.1111/jdv.16139. Epub 2020 Jan 6. PMID: 31814161.
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses
Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L. J Invest Dermatol. 2018 Jun;138(6):1293-1300. doi: 10.1016/j.jid.2017.12.034. Epub 2018 Jan 31. PMID: 29369774.

Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis
Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, Wolkenstein P, Royer G, Ezzedine K, Muraine M, Gueudry J. Br J Dermatol. 2019 Jul;181(1):212-213. doi: 10.1111/bjd.17627. Epub 2019 Apr 29. PMID: 30633324.
Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae
Hajj C, Ezzedine K, Thorel D, Delcampe A, Royer G, Hua C, Colin A, de Prost N, Muraine M, Chosidow O, Wolkenstein P, Gueudry J, Ingen-Housz-Oro S. Br J Dermatol. 2019 Aug;181(2):421-422. doi: 10.1111/bjd.18023. Epub 2019 Jun 6. PMID: 31016732. No abstract available.
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases
Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B. Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4. PMID: 30511379. Free PMC article.
Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance
Chaby G, Lebrun-Vignes B, Haddad C, Hemery F, Ingen-Housz-Oro S, de Prost N, Wolkenstein P, Chosidow O, Fardet L. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1344-1346. doi: 10.1016/j.jaip.2018.09.028. Epub 2018 Oct 5. PMID: 30292922. No abstract available.

Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'
Dumas M, Hua C, Hotz C, Velter C, Duong TA, Maraffi T, Ortonne N, Hüe S, Fardet L, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O. J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e360-e361. doi: 10.1111/jdv.14935. Epub 2018 Mar 30. PMID: 29524279. No abstract available.
Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)
Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses. Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7. PMID: 29636107. Free PMC article.

Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series
Gendreau S, Amiot A, Le Baleur Y, Charpy C, Wolkenstein P, Chosidow O, Mekontso Dessap A, Ingen-Housz-Oro S, de Prost N. Br J Dermatol. 2019 May;180(5):1234-1235. doi: 10.1111/bjd.17428. Epub 2019 Feb 13. PMID: 30430542. No abstract available.

Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients
Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N, Br J Dermatol. 2020 Apr;182(4):916-926. doi: 10.1111/bjd.18387. Epub 2019 Oct 15. PMID: 31385287.

Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics
Chaby G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, Chosidow O, Fardet L. J Am Acad Dermatol. 2019 May;80(5):1453-1455. doi: 10.1016/j.jaad.2018.10.058. Epub 2018 Nov 2. PMID: 30395917. No abstract available.
Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases
Brin C, Bernigaud C, Hua C, Duong TA, Gaudin O, Colin A, de Prost N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S. Ann Dermatol Venereol. 2021 Apr 12:S0151-9638(21)00029-6. doi: 10.1016/j.annder.2021.02.002. Epub ahead of print. PMID: 33858692.
Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases
Lecadet A, Woerther PL, Hua C, Colin A, Gomart C, Decousser JW, Mekontso Dessap A, Wolkenstein P, Chosidow O, de Prost N, Ingen-Housz-Oro S. J Am Acad Dermatol. 2019 Aug;81(2):342-347. doi: 10.1016/j.jaad.2019.03.030. Epub 2019 Mar 16. PMID: 30890340. Clinical Trial.
Incidence of mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate
Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, Gonzalez-Chiappe S, Wolkenstein P, Chosidow O, Mahr A, Fardet L. Br J Dermatol. 2020 Mar;182(3):618-624. doi: 10.1111/bjd.18424. Epub 2019 Oct 22. PMID: 31396952.
Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016
Traikia C, Hua C, Le Cleach L, de Prost N, Hemery F, Bettuzzi T, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Sbidian E. Br J Dermatol. 2020 Apr;182(4):900-906. doi: 10.1111/bjd.18294. Epub 2019 Sep 4. PMID: 31260078.
Interventions for erythema multiforme: a systematic review
De Risi-Pugliese T, Sbidian E, Ingen-Housz-Oro S, Le Cleach L. J Eur Acad Dermatol Venereol. 2019 May;33(5):842-849. doi: 10.1111/jdv.15447. Epub 2019 Feb 28. PMID: 30680804.
Involvement of small-diameter nerve fibres in long-term chronic pain after Stevens-Johnson syndrome or toxic epidermal necrolysis. A neurophysiological assessment
Lefaucheur JP, Hajj C, Valeyrie-Allanore L, Colin A, Ng Wing Tin S, de Prost N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S. J Eur Acad Dermatol Venereol. 2020 Sep 13. doi: 10.1111/jdv.16940. Epub ahead of print. PMID: 32920914.

Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme
Drahy F, Ingen-Housz-Oro S, Grootenboer-Mignot S, Wolkenstein P, Chosidow O. JAMA Dermatol. 2018 Apr 1;154(4):487-489. doi: 10.1001/jamadermatol.2017.5889. PMID: 29450445 No abstract available.

Maladies rares en dermatologie : rôle du service social pour les patients adultes. Exemple de la nécrolyse épidermique [Rare dermatological diseases: The role of social workers regarding adult patients. The example of epidermal necrolysis]
Bourgeois A, Colin A, Redlich J, de Prost N, Ingen-Housz-Oro S. Ann Dermatol Venereol. 2020 Apr;147(4):318-321. French. doi: 10.1016/j.annder.2020.01.010. Epub 2020 Feb 19. PMID: 32087980.
Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement
Thorel D, Ingen-Housz-Oro S, Royer G, Delcampe A, Bellon N, Bodemer C, Welfringer-Morin A, Bremond-Gignac D, Robert MP, Tauber M, Malecaze F, Dereure O, Daien V, Colin A, Bernier C, Couret C, Vabres B, Tetart F, Milpied B, Cornut T, Ben Said B, Burillon C, Cordel N, Beral L, de Prost N, Wolkenstein P, Muraine M, Gueudry J, Orphanet J Rare Dis. 2020 Sep 22;15(1):259. doi: 10.1186/s13023-020-01538-x. PMID: 32962748; PMCID: PMC7510143.
Massive clonal expansion of polycytotoxic skin and blood CD8 + T cells in patients with toxic epidermal necrolysis
Axel Patrice Villani, Aurore Rozieres, Benoît Bensaid, Klara Kristin Eriksson, Amandine Mosnier, Floriane Albert, Virginie Mutez, Océane Brassard, Tugba Baysal, Mathilde Tardieu, Omran Allatif, Floriane Fusil, Thibault Andrieu, Denis Jullien, Valérie Dubois, Catherine Giannoli, Henri Gruffat, Marc Pallardy, François-Loïc Cosset, Audrey Nosbaum , Osami Kanagawa, Janet L Maryanski, Daniel Yerly, Jean-François Nicolas, Marc Vocanson.PMID: 33741590 PMCID: PMC7978430 DOI: 10.1126/sciadv.abe0013.

Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients
Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong TA, Colin A, Bellivier F, Romano H, de Prost N, Chazelas K, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S. Br J Dermatol. 2019 May;180(5):1206-1213. doi: 10.1111/bjd.17267. Epub 2018 Dec 3. PMID: 30282109.
Primary cutaneous mucormycosis as a complication of erosive dermatitis: two cases
Lu D, Hua C, Servy A, Foulet F, Botterel F, De Prost N, Ellrodt O, Sigha B, Popescu D, Ortonne N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O. Eur J Dermatol. 2018 Apr 1;28(2):227-229. doi: 10.1684/ejd.2017.3212. PMID: 29171398. No abstract available.

Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients
Papo M, Valeyrie-Allanore L, Razazi K, Carteaux G, Wolkenstein P, Chosidow O, Brun-Buisson C, Mekontso Dessap A, de Prost N. Br J Dermatol. 2017 May;176(5):1370-1372. doi: 10.1111/bjd.14934. Epub 2017 Feb 28. PMID: 27510226 Clinical Trial. No abstract available.
Rituximab, a new treatment for difficult-to-treat chronic erythema multiforme major? Five cases
Hirsch G, Ingen-Housz-Oro S, Fite C, Valeyrie-Allanore L, Ortonne N, Buffard V, Verlinde-Carvalho M, Marinho E, Martinet J, Grootenboer-Mignot S, Descamps V, Wolkenstein P, Joly P, Chosidow O. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1140-3. doi: 10.1111/jdv.13313. Epub 2015 Sep 15. PMID: 26369288

Severe cutaneous adverse reactions to drugs
Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Lancet 2017; published online May 2.
Severe sequelae of erythema multiforme: three cases
Viarnaud A, Ingen-Housz-Oro S, Marque M, Valeyrie-Allanore L, Ortonne N, Gueudry J, Grootenboer-Mignot S, Muraine M, Bequignon E, Gagnière C, Schlemmer F, Wolkenstein P, Chosidow O. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e34-e36. doi: 10.1111/jdv.14478. Epub 2017 Sep 6. PMID: 28710842 No abstract available.
Supplementary appendix to severe cutaneous adverse reactions to drugs
This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Lancet 2017; published online May 2.
Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug
Velter C, Hotz C, Ingen-Housz-Oro S, Wolkenstein P, Fardet L. JAMA Dermatol. 2018 Feb 1;154(2):224-225. doi: 10.1001/jamadermatol.2017.4607. PMID: 29261833. No abstract available.
Strong reactions to diltiazem patch tests: Plea for a low concentration. Contact Dermatitis
Assier H, Ingen-Housz-Oro S, Zehou O, Hirsch G, Chosidow O, Wolkenstein P. 2020 Sep;83(3):224-225. doi: 10.1111/cod.13554. Epub 2020 Apr 30. PMID: 32281655.
Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
Brüggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, Didona B, Colin A, Horváth B, Brezinova E, Milpied B, Moss C, Bodemer C, Meyersburg D, Salavastru, C, Tiplica GS, Howard E, Bequignon E, Bouwes Bavinck JN, Newman J, Gueudry J, Nägeli M, Zaghbib K, Pallesen K, Bygum A, Joly P, Wolkenstein P, Chua SL, Le Floch R, Shear NH, Chu CY, Hama N, Abe R, Chung WH, Shiohara T, Arden-Jones M, Romanelli P, Phillips EJ, Stern RS, Cotliar J, Micheletti RG, Brassard A, Schulz JT, Dodiuk-Gad RP, Dominguez AR, Paller AS, Vidal LS, Mostaghimi A, Noe MH, Worswick S, Tartar D, Sheridan R, Kaffenberger BH, Shinkai K, Maverakis E, French LE, Ingen-Housz-Oro S. Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19893. Epub ahead of print. PMID: 33657677.

The diagnosis is in the rings
Ingen-Housz-Oro S, Ortonne N, Chosidow O. BMJ. 2017 Oct 5;359:j3817. doi: 10.1136/bmj.j3817. PMID: 28982958 No abstract available.
Toward a better understanding of adult idiopathic epidermal necrolysis. A retrospective study of 19 cases.
Monnet P, Rodriguez C, Gaudin O, Cirotteau P, Papouin B, Dereure O, Tetart F, Lalevee S, Colin A, Lebrun-Vignes B, Abe E, Alvarez JC, Demontant V, Gricourt G, de Prost N, Barau C, Chosidow O, Wolkenstein P, Hue S, Ortonne N, Milpied B, Ingen-Housz-Oro S. J Eur Acad Dermatol Venereol. 2021 Apr 8. doi: 10.1111/jdv.17274. Epub ahead of print. PMID: 33834541.
Treatment of severe cutaneous adverse drug reactions
Ingen-Housz-Oro S, Duong TA, de Prost N, Colin A, Fardet L, Lebrun-Vignes B, Barbaud A, Chosidow O, Wolkenstein P; centre de référence des dermatoses bulleuses toxiques et toxidermies graves et le FISARD. Ann Dermatol Venereol. 2018 Jun-Jul;145(6-7):454-464. doi: 10.1016/j.annder.2018.02.014. Epub 2018 Apr 13. PMID: 29657073 French. No abstract available.
Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017
Bettuzzi T, Penso L, de Prost N, Hemery F, Hua C, Colin A, Mekontso-Dessap A, Fardet L, Chosidow O, Wolkenstein P, Sbidian E, Ingen-Housz-Oro S. Br J Dermatol. 2020 Jan;182(1):247-248. doi: 10.1111/bjd.18360. Epub 2019 Sep 11. PMID: 31323695 No abstract available.

Publications PubMed.gov

Acute generalized exanthematous pustulosis (AGEP)
S.Ingen-Housz-Oro, D.Staumont-Sallé, B.Bensaid. doi.org/10.1016/j.fander.2020.07.008

DRESS: drug reaction with eosinophilia and systemic symptoms
S.Ingen-Housz-Oro, B.Milpied, B.Bensaid, V.Descamps. doi.org/10.1016/j.fander.2020.07.003

Erythema multiforme
S.Ingen-Housz-Oro, A.Welfringer-Morin. doi.org/10.1016/j.fander.2020.12.010

Relapsing generalized bullous fixed drug eruption: a severe and avoidable cutaneous drug reaction. Three case reports
Clément Braesch, Amandine Weill, Olivier Gaudin, Bénédicte Lebrun-Vignes, Charlotte Bernigaud, Camille Hua, Nicolas Ortonne, Lionel Nakad, Véronique Chambrin, Olivier Chosidow, Pierre Wolkenstein, Laure Thomas, Haudrey Assier, Saskia Ingen-Housz-Oro. doi.org/10.1016/j.therap.2021.04.004

Treating maculopapular exanthema
S.Ingen-Housz-Oro, F.Tétart, B.Milpied. doi.org/10.1016/j.fander.2020.07.007

Publications ScienceDirect